A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Moderate Renal Impairment and Normal Renal Function

NCT07694869 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants
Participants With Moderate Renal Impairment

Interventions

DRUG: ammoxetine hydrochloride enteric-coated tablets

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.